Wells Fargo & Company Adma Biologics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 648,275 shares of ADMA stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

648,275

Previous 641,038 1.13%

Holding current value

$13.9 Million

Previous $7.17 Million 80.84%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$11.21 - $20.03 $81,126 - $144,957	7,237 Added 1.13%	648,275 $13 Million
Q2 2024 Aug 13, 2024	BUY	$5.98 - $11.18 $3.29 Million - $6.14 Million	549,357 Added 599.2%	641,038 $7.17 Million
Q1 2024 May 10, 2024	BUY	$4.4 - $6.74 $50,881 - $77,941	11,564 Added 14.43%	91,681 $605,000
Q4 2023 Feb 09, 2024	SELL	$3.08 - $4.52 $368,851 - $541,301	-119,757 Reduced 59.92%	80,117 $362,000
Q3 2023 Nov 13, 2023	SELL	$3.47 - $4.61 $161,174 - $214,125	-46,448 Reduced 18.86%	199,874 $715,000
Q2 2023 Aug 15, 2023	BUY	$3.12 - $4.22 $71,192 - $96,291	22,818 Added 10.21%	246,322 $908,000
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $652,865 - $839,399	216,899 Added 3283.86%	223,504 $739,000
Q4 2022 Feb 13, 2023	SELL	$2.47 - $3.88 $13,328 - $20,936	-5,396 Reduced 44.96%	6,605 $25,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $1,636 - $2,305	806 Added 7.2%	12,001 $29,000
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $2,273 - $3,498	1,590 Added 16.55%	11,195 $22,000
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $1,146 - $1,639	-896 Reduced 8.53%	9,605 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $381 - $581	-350 Reduced 3.23%	10,501 $14,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $2,786 - $4,068	-2,466 Reduced 18.52%	10,851 $12,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $31,151 - $42,704	-20,630 Reduced 60.77%	13,317 $21,000
Q1 2021 May 13, 2021	SELL	$1.67 - $2.95 $242,928 - $429,124	-145,466 Reduced 81.08%	33,947 $60,000
Q4 2020 Feb 09, 2021	BUY	$1.8 - $2.56 $18,910 - $26,895	10,506 Added 6.22%	179,413 $351,000
Q3 2020 Nov 05, 2020	SELL	$2.04 - $3.74 $8,015 - $14,694	-3,929 Reduced 2.27%	168,907 $403,000
Q2 2020 Aug 13, 2020	BUY	$2.42 - $3.29 $104,892 - $142,601	43,344 Added 33.47%	172,836 $507,000
Q1 2020 May 14, 2020	BUY	$1.5 - $4.59 $194,238 - $594,368	129,492 New	129,492 $372,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.22B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Adma Biologics, Inc. Transaction History